The generic drugmakers, with many more expected to make announcements, are eyeing a share of the market for Semaglutide in India, which is estimated to be $1 billion over the next couple of years
Sun Pharma, Dr. Reddy’s, Zydus, Glenmark roll out generic Semaglutide